• Skip to Content
  • Skip to Main Navigation
  • Skip to Search

IU

Indiana University Bloomington Indiana University Bloomington IU Bloomington

Menu Open Search

The College of Arts & Sciences

Zlotnick Lab

  • Home
  • News
  • Members
    • Current Members
    • Alumni
  • Publications
  • Research
  • Photos
  • Contact
  • Search
  • #446 (no title)
  • Alumni
  • Contact
  • Current Members
  • Home
  • IU researchers investigate key protein in COVID-19 virus that could lead to effective new treatments
  • Members
  • News
  • Photos
  • Privacy
  • Publications
  • Research
  • Home
  • Assembly Biosciences and Door Pharmaceuticals sign agreement to collaborate on development of a novel class of HBV core protein modulators.

Assembly Biosciences and Door Pharmaceuticals sign agreement to collaborate on development of a novel class of HBV core protein modulators.

By:chemweb

November 16, 2020

Spotlight Image

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB) and Door
Pharmaceuticals, LLC today announced that the companies have signed an exclusive, two-year collaboration and option
agreement focused on the development of a novel class of hepatitis B virus (HBV) core protein modulators. Door Pharmaceuticals’
innovative discovery platform targets functions of core protein distinct from viral assembly and that have the potential to interfere
with viral nucleic acid including cccDNA transcription, providing a strong complement to Assembly Bio’s current portfolio.

Read the press release here.


Previous
Next
  • The College of Arts & Sciences
  • Zlotnick Lab

The College of Arts & Sciences

Fulfilling the Promise

Indiana University

Copyright © 2018 The Trustees of Indiana University

Privacy Notice | Accessibility Help

  • Home
  • News
  • Members
    • Current Members
    • Alumni
  • Publications
  • Research
  • Photos
  • Contact

The College of Arts & Sciences